84 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Amhtm1Bhr/Amhtm1Bhr ArTfm/Y either: (involves: 129P3/J * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)	abnormal male reproductive system morphology	J:21396
	abnormal secondary sex determination	J:21396
	absent epididymis	J:21396
	absent vas deferens	J:21396
	arrest of spermatogenesis	J:21396
	cryptorchism	J:21396
	male pseudohermaphroditism	J:21396
	secondary sex reversal	J:21396
ArTfm/Ar+ EdaTa-25H/Eda+ involves: 101/H * C3H/HeH	abnormal coat/hair pigmentation	J:11266
	abnormal cranium size	J:11266
	decreased body size	J:11266
	domed cranium	J:11266
	exencephaly	J:11266
	irregular coat pigmentation	J:11266
	neonatal lethality, incomplete penetrance	J:11266
	polydactyly	J:11266
	prenatal lethality, incomplete penetrance	J:11266
	striated fur	J:11266
	supernumerary incisors	J:11266
	syndactyly	J:11266
	transverse fur striping	J:11266
ArTfm/Ar+ Lactb2Tg(Igh-Meis1)2770Amb/Lactb2Tg(Igh-Meis1)2770Amb involves: FVB/NJ	normal mortality/aging	J:79618
ArTfmEdaTa-25H/Y involves: 101/H * C3H/HeH	abnormal coat/hair pigmentation	J:11266
	decreased body size	J:11266
	exencephaly	J:11266
	irregular coat pigmentation	J:11266
	male pseudohermaphroditism	J:11266
	neonatal lethality, incomplete penetrance	J:11266
	prenatal lethality, incomplete penetrance	J:11266
	striated fur	J:11266
	transverse fur striping	J:11266
ArTfm/Y Insl3tm1Imad/Insl3tm1Imad involves: 129/Sv * CD-1 * STOCK EdaTa	abnormal female reproductive system morphology	J:83429
	abnormal gubernaculum morphology	J:83429
	abnormal male reproductive system morphology	J:83429
	abnormal secondary sex determination	J:83429
	absent epididymis	J:83429
	absent vas deferens	J:83429
	bilateral cryptorchism	J:83429
	male pseudohermaphroditism	J:83429
ArTfm/Y Tg(TSPY)9Jshm/0 involves: NMRI * STOCK EdaTa Atp7aMo-blo	abnormal seminiferous tubule morphology	J:140803
	arrest of male meiosis	J:140803
	cryptorchism	J:140803
	enlarged seminiferous tubules	J:140803
	increased Leydig cell number	J:140803
	increased testis tumor incidence	J:140803
	increased testis weight	J:140803
	secondary sex reversal	J:140803
Artm1(AR)Dmr/Y involves: 129S1/Sv * C57BL/6J	increased body weight	J:108849
	increased percent body fat/body weight	J:108849
Artm1(AR)Dmr/Y Tg(TRAMP)8247Ng/0 involves: 129S1/Sv * C57BL/6	increased prostate gland tumor incidence	J:108849
Artm1Verh/Y Ptentm1Hwu/Ptentm1Hwu Tg(Pbsn-cre)4Prb/0 involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2	increased prostate gland adenocarcinoma incidence	J:172730
Artm2(AR)Dmr/Y involves: 129S1/Sv * C57BL/6J	normal reproductive system phenotype	J:104360
Artm2(AR)Dmr/Y Tg(TRAMP)8247Ng/0 involves: 129S1/Sv * C57BL/6	increased prostate gland tumor incidence	J:108849
Artm3(AR)Dmr/Y involves: 129S1/Sv * C57BL/6J	normal behavior/neurological phenotype	J:114552
	normal growth/size/body region phenotype	J:114552
	increased body weight	J:108849
	increased percent body fat/body weight	J:108849
	normal muscle phenotype	J:114552
	normal nervous system phenotype	J:114552
	normal reproductive system phenotype	J:104360
Artm3(AR)Dmr/Y Tg(TRAMP)8247Ng/0 involves: 129S1/Sv * C57BL/6	decreased tumor incidence	J:108849
Artm3.1(AR)Ska/Y involves: C57BL/6 * C57BL/6J * CBA	decreased prostate gland weight	J:170092
	increased circulating testosterone level	J:170092
	reduced fertility	J:170092
	small prostate gland	J:170092
	small seminiferous tubules	J:170092
Artm3.1(AR)Ska/Y Tg(KLKB1-cre/ERT2)1Pcn/0 involves: C57BL/6 * C57BL/6J * CBA	abnormal prostate gland physiology	J:170092
	increased circulating testosterone level	J:170092
	increased prostate gland ventral lobe weight	J:170092
	increased prostate gland weight	J:170092
	reduced fertility	J:170092
Artm3.1(AR)Ska/Y Tg(KLKB1-cre/ERT2)1Pcn/0 Tg(TRAMP)8247Ng/0 involves: C57BL/6 * C57BL/6J * CBA	abnormal tumor morphology	J:170092
	decreased tumor latency	J:170092
	increased prostate gland tumor incidence	J:170092
	increased tumor growth/size	J:170092
	premature death	J:170092
Artm4(AR)Dmr/Y involves: 129S1/Sv * C57BL/6J	abnormal blood homeostasis	J:114552
	abnormal cell cytoskeleton morphology	J:104360
	abnormal muscle electrophysiology	J:114552
	abnormal seminiferous tubule morphology	J:114552
	abnormal Sertoli cell morphology	J:104360
	abnormal skeletal muscle fiber morphology	J:114552
	abnormal spermatogenesis	J:104360
	abnormal spinal cord morphology	J:114552
	abnormal testis morphology	J:104360
	centrally nucleated skeletal muscle fibers	J:114552
	decreased body size	J:114552
	decreased body weight	J:114552
	decreased circulating follicle stimulating hormone level	J:104360
	decreased circulating testosterone level	J:114552
	decreased grip strength	J:114552
	decreased testis weight	J:104360
	decreased urine major urinary protein level	J:104360
	distended urinary bladder	J:114552
	impaired muscle relaxation	J:114552
	increased blood urea nitrogen level	J:114552
	increased circulating creatinine level	J:114552
	increased circulating luteinizing hormone level	J:104360
	increased circulating potassium level	J:114552
	increased variability of skeletal muscle fiber size	J:114552
	motor neuron degeneration	J:114552
	muscle weakness	J:114552
	myopathy	J:114552
	oligozoospermia	J:104360
	premature death	J:114552
	progressive muscle weakness	J:114552
	reduced male fertility	J:104360, J:114552
	skeletal muscle fiber atrophy	J:114552
	testicular atrophy	J:104360, J:114552
Artm4(AR)Dmr/Ar+ involves: 129S1/Sv * C57BL/6J	decreased grip strength	J:114552
	normal growth/size/body region phenotype	J:114552
	increased circulating testosterone level	J:114552
	increased urine major urinary protein level	J:114552
	normal mortality/aging	J:114552
	muscle weakness	J:114552